Kerala Institute of Medical Sciences
Trivandrum, India
Private hospital in Thiruvananthapuram, Kerala
1, Vinod Nagar Rd, Anayara, Thiruvananthapuram, Kerala 695029
About Kerala Institute of Medical Sciences
"KIMSHEALTH is the foundation for good health and wellness! Since 2002, we have kept our patients at the heart of our care and have committed ourselves to providing quality and affordable healthcare. KIMSHEALTH cares for over 2.5 million local and international patients annually through our multidisciplinary team of over 900 doctors and 6,000 healthcare professionals in India, Bahrain, Oman, Saudi Arabia, Qatar and the UAE. Our national and international accreditations demonstrate some of the highest clinical success rates and signify our strict quality and safety standards."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Kerala Institute of Medical Sciences
During the past decade, Kerala Institute of Medical Sciences conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Japanese Phase 1/2 Study to Assess the Efficacy, Safety and Pharmacokinetics of Romidepsin in Patients With Peripheral T-cell Lymphoma (PTCL)
2011-12-01
2018-12-14
Completed
51
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
2016-09-01
2023-08-01
Active, not recruiting
539
A Study of Fedratinib in Japanese Subjects With DIPSS (Dynamic International Prognostic Scoring System)- Intermediate or High-risk Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (Post-PV MF), or Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
2020-10-12
2025-06-30
Recruiting
31
To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)
2021-05-26
2025-06-01
Active, not recruiting
212
To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)
2021-05-27
2026-05-23
Recruiting
440
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions
2021-02-25
2025-08-23
Recruiting
309
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
2022-06-23
2033-01-26
Recruiting
864
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kerala Institute of Medical Sciences" #1 sponsor was "CymaBay Therapeutics, Inc." with 1 trials, followed by "Human Genome Sciences Inc." with 1 trials
sponsored, "Northwestern University" with 1 trials sponsored, "Sandoz" with 1 trials sponsored and "St. John's Research Institute"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kerala Institute of Medical Sciences"
#1 collaborator was "Cadila Pharnmaceuticals" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Indian Society of Critical Care Medicine" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Kerala Institute of Medical Sciences
According to Clinical.Site data, the most researched conditions in "Kerala Institute of Medical Sciences" are
"Acute Coronary Syndrome" (1 trials), "Anemia" (1 trials), "Cardiovascular Diseases" (1 trials), "Chronic Renal Insufficiency" (1 trials) and "Septic Shock" (1 trials). Many other conditions were trialed in "Kerala Institute of Medical Sciences" in a lesser frequency.
Clinical Trials Intervention Types at Kerala Institute of Medical Sciences
Most popular intervention types in "Kerala Institute of Medical Sciences" are "Drug" (4 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Actos" (1 trials), "Belimumab 1 mg/kg" (1 trials), "Belimumab 10 mg/kg" (1 trials) and "ERYPO" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kerala Institute of Medical Sciences
The vast majority of trials in "Kerala Institute of Medical Sciences" are
6 trials for "All" genders.
Clinical Trials Status at Kerala Institute of Medical Sciences
Currently, there are NaN active trials in "Kerala Institute of Medical Sciences".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Kerala Institute of Medical Sciences,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kerala Institute of Medical Sciences, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".